No Picture
News

Denovo Biopharma Receives FDA’s Permission to Proceed with a Biomarker-Guided Phase 2b Clinical Trial with DB102 (Enzastaurin) In First-Line Treatment of Glioblastoma (GBM)

SAN DIEGO, Oct. 15, 2019 /PRNewswire/ — Denovo Biopharma LLC, a pioneer in applying precision medicine to develop innovative therapies, today announced FDA’s approval to initiate Denovo’s Phase 2b clinical study of DB102 in patients with newly-diag… […]

No Picture
News

Neurocrine Biosciences Announces Conference Call and Webcast of Third Quarter 2019 Financial Results

Conference Call and Webcast Scheduled for Monday, November 4

SAN DIEGO, Oct. 14, 2019 /PRNewswire/ — Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that it will report third quarter financial results after the Nasdaq market closes on Mo… […]

No Picture
News

Aethlon Announces Reverse Stock Split

SAN DIEGO, Oct. 14, 2019 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD) (“Aethlon” or the “Company”), a therapeutic medical device and technology company focused on unmet needs in global health, announced today that at the annual meeting of st… […]

No Picture
News

Immunic, Inc. Announces Completion of Enrollment for its Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis

– Milestone Achieved Nine Months Ahead of Initial Schedule; Top-Line Data Expected in Q3 2020 –

SAN DIEGO, Oct. 10, 2019 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, ora… […]

No Picture
News

DelMar Pharmaceuticals to Present at the Inaugural MicroCap Rodeo Investor Conference on October 15, 2019 at 11:30 AM Central Time

SAN DIEGO, Oct. 10, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of new cancer therapies, announced that Mr. Saiid Zarrabian, Chief Executive Off… […]

No Picture
News

AFYX Therapeutics Presents Results from Rivelin Clinical Proof of Concept Study in Patients with Vulvar Lichen Sclerosus at the 2019 European Academy of Dermatology and Venereology Congress

SAN DIEGO and COPENHAGEN, Denmark, Oct. 9, 2019 /PRNewswire/ — AFYX Therapeutics, a clinical stage biopharmaceutical company developing innovative approaches to treat mucosal diseases, today announced results from a Phase 1 clinical proof of concep… […]